Abstract PO5-04-05: Clinical Validation of the Concordance Performance of ERBB2 Status by Single-Cells Genomics ERBB2 (HER2) Amplification Assay in Circulating Tumor Cells (ctcs) from Patients with Matched HER2 Status from Metastatic Tissue Biopsies